Presentation on Special Situation Opportunities in the Indian Stock Markets

It feels great to share with you an important piece of update on the work front. Recently, I got an opportunity to address the 2nd Year MBA students of MDI, Gurgaon, a premier Business school, consistently ranked in the top 10. The address was a part of the Behavioral Finance & Business Valuation (BFBV) course as covered by Prof. Sanjay Bakshi and the topic was Special Situation Opportunities in the Indian Stock Markets. Despite the initial nervousness, the presentation went…

Read More

How to Identify Stocks with Low Downside Risk and Potential for Large Gains?…Backed with Examples

Dear Sir, Hope you are doing well. Today, I would like to share with you our thought process on how to identify stocks with low downside risk and potential for high pay offs. I think you will agree with the following two facts: All the businesses are cyclical to varying extents and go through lean periods, and Best returns are generated when a company goes through both Earnings and PE expansion Thus, if you combine the two, we get the…

Read More

[Recommendation] – Delisting Opportunity – Low Downside and Expecting Promoters to buy out at higher price

Dear Sir, It’s always great to participate in Special situation opportunities (SSOs) as there can be decent gains in relatively shorter duration of 3-4 months. We have also benefited from this strategy with several Special Situation opportunities like Ineos Styrosolution delisting, Suven life-Suven Pharma demerger, Linde India delisting, Hexaware delisting, Xchanging Solutions delisting, etc appreciating by 20-140% in a period of 2-11 months. So, just 2 days back we released our New Special Situation stock report and we think you may find the logic behind the same interesting as there’s a…

Read More

[New Stock Recommendation] – 0 to 1000 crore + sales in 18 years…Stock at 12-13 PE

Hope you all are doing good and taking proper precautions. We recently shared our new stock recommendation with our Premium Members and would like to share with you details about the same. As discussed in our Risk categorization update, we have been focusing on leading well-managed companies which will probably emerge stronger from this pandemic and capture higher market share in the years to come. Have also benefited from this strategy with stocks like Aarti Drugs, Suven Pharma, Chaman Lal,…

Read More
Copy Protected by Chetan's WP-Copyprotect.